Cell line development
Developing efficient, GMP-ready cell lines for the manufacturing of your biologics
Our microbial and mammalian cell line development services are very well adapted to biopharma companies with challenging molecules looking for a partner offering expertise, flexibility and guidance.
Diversity of GMP compliant platforms for the manufacturing of biotherapeutics
Our team has experience in both microbial and mammalian cell line development using established, efficient, and GMP compliant platforms:
- E. coli
- P. pastoris
- CHO-K1, CHO-S (available in 2020)
Focused on the success of your project, we will suggest the most appropriate expression platform based on the nature of your protein and your IP constraints. In addition, we adapt our cell line development services to include tailored product quality analysis at key points of the process and ensure that your critical product attributes targets are met.
Integrated CDMO services from R&D to cGMP manufacturing
Our cell line development services can be used as stand-alone services but are more often integrated into larger process development programmes including upstream & downstream process development as well as the development of supporting analytical methods for further GMP production of biotherapeutics.
